790 related articles for article (PubMed ID: 28314593)
21. Heterologous Protection against Asian Zika Virus Challenge in Rhesus Macaques.
Aliota MT; Dudley DM; Newman CM; Mohr EL; Gellerup DD; Breitbach ME; Buechler CR; Rasheed MN; Mohns MS; Weiler AM; Barry GL; Weisgrau KL; Eudailey JA; Rakasz EG; Vosler LJ; Post J; Capuano S; Golos TG; Permar SR; Osorio JE; Friedrich TC; O'Connor SL; O'Connor DH
PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005168. PubMed ID: 27911897
[TBL] [Abstract][Full Text] [Related]
22. Zika Virus: Emergence, Phylogenetics, Challenges, and Opportunities.
Rajah MM; Pardy RD; Condotta SA; Richer MJ; Sagan SM
ACS Infect Dis; 2016 Nov; 2(11):763-772. PubMed ID: 27704772
[TBL] [Abstract][Full Text] [Related]
23. Probing Molecular Insights into Zika Virus⁻Host Interactions.
Lee I; Bos S; Li G; Wang S; Gadea G; Desprès P; Zhao RY
Viruses; 2018 May; 10(5):. PubMed ID: 29724036
[TBL] [Abstract][Full Text] [Related]
24. Chloroquine inhibits endosomal viral RNA release and autophagy-dependent viral replication and effectively prevents maternal to fetal transmission of Zika virus.
Zhang S; Yi C; Li C; Zhang F; Peng J; Wang Q; Liu X; Ye X; Li P; Wu M; Yan Q; Guo W; Niu X; Feng L; Pan W; Chen L; Qu L
Antiviral Res; 2019 Sep; 169():104547. PubMed ID: 31251958
[TBL] [Abstract][Full Text] [Related]
25. Structure-activity relationship of flavonoid bifunctional inhibitors against Zika virus infection.
Zou M; Liu H; Li J; Yao X; Chen Y; Ke C; Liu S
Biochem Pharmacol; 2020 Jul; 177():113962. PubMed ID: 32272109
[TBL] [Abstract][Full Text] [Related]
26. Antiviral activity of N-(4-hydroxyphenyl) retinamide (4-HPR) against Zika virus.
Pitts JD; Li PC; de Wispelaere M; Yang PL
Antiviral Res; 2017 Nov; 147():124-130. PubMed ID: 29051080
[TBL] [Abstract][Full Text] [Related]
27. Zika Virus Targeting in the Developing Brain.
van den Pol AN; Mao G; Yang Y; Ornaghi S; Davis JN
J Neurosci; 2017 Feb; 37(8):2161-2175. PubMed ID: 28123079
[TBL] [Abstract][Full Text] [Related]
28. Chloroquine, an Endocytosis Blocking Agent, Inhibits Zika Virus Infection in Different Cell Models.
Delvecchio R; Higa LM; Pezzuto P; Valadão AL; Garcez PP; Monteiro FL; Loiola EC; Dias AA; Silva FJ; Aliota MT; Caine EA; Osorio JE; Bellio M; O'Connor DH; Rehen S; de Aguiar RS; Savarino A; Campanati L; Tanuri A
Viruses; 2016 Nov; 8(12):. PubMed ID: 27916837
[TBL] [Abstract][Full Text] [Related]
29. Zika Virus Induced Mortality and Microcephaly in Chicken Embryos.
Goodfellow FT; Tesla B; Simchick G; Zhao Q; Hodge T; Brindley MA; Stice SL
Stem Cells Dev; 2016 Nov; 25(22):1691-1697. PubMed ID: 27627457
[TBL] [Abstract][Full Text] [Related]
30. Zika Virus-Associated Microcephaly and Eye Lesions in the Newborn.
Valentine G; Marquez L; Pammi M
J Pediatric Infect Dis Soc; 2016 Sep; 5(3):323-8. PubMed ID: 27405738
[TBL] [Abstract][Full Text] [Related]
31. The Viral Polymerase Inhibitor 7-Deaza-2'-C-Methyladenosine Is a Potent Inhibitor of In Vitro Zika Virus Replication and Delays Disease Progression in a Robust Mouse Infection Model.
Zmurko J; Marques RE; Schols D; Verbeken E; Kaptein SJ; Neyts J
PLoS Negl Trop Dis; 2016 May; 10(5):e0004695. PubMed ID: 27163257
[TBL] [Abstract][Full Text] [Related]
32. The celecoxib derivative kinase inhibitor AR-12 (OSU-03012) inhibits Zika virus via down-regulation of the PI3K/Akt pathway and protects Zika virus-infected A129 mice: A host-targeting treatment strategy.
Chan JF; Zhu Z; Chu H; Yuan S; Chik KK; Chan CC; Poon VK; Yip CC; Zhang X; Tsang JO; Zou Z; Tee KM; Shuai H; Lu G; Yuen KY
Antiviral Res; 2018 Dec; 160():38-47. PubMed ID: 30326204
[TBL] [Abstract][Full Text] [Related]
33. A synthetic derivative of houttuynoid B prevents cell entry of Zika virus.
Basic M; Elgner F; Bender D; Sabino C; Herrlein ML; Roth H; Glitscher M; Fath A; Kerl T; Schmalz HG; Hildt E
Antiviral Res; 2019 Dec; 172():104644. PubMed ID: 31697958
[TBL] [Abstract][Full Text] [Related]
34. ICR suckling mouse model of Zika virus infection for disease modeling and drug validation.
Wu YH; Tseng CK; Lin CK; Wei CK; Lee JC; Young KC
PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006848. PubMed ID: 30356305
[TBL] [Abstract][Full Text] [Related]
35. Antiviral effect of 25-hydroxycholesterol against porcine reproductive and respiratory syndrome virus in vitro.
Dong H; Zhou L; Ge X; Guo X; Han J; Yang H
Antivir Ther; 2018; 23(5):395-404. PubMed ID: 29561734
[TBL] [Abstract][Full Text] [Related]
36. Synergistic antiviral activity of Sofosbuvir and type-I interferons (α and β) against Zika virus.
Snyder B; Goebel S; Koide F; Ptak R; Kalkeri R
J Med Virol; 2018 Jan; 90(1):8-12. PubMed ID: 28851097
[TBL] [Abstract][Full Text] [Related]
37. Zika virus: An emerging challenge for obstetrics and gynecology.
Lin JJ; Chin TY; Chen CP; Chan HL; Wu TY
Taiwan J Obstet Gynecol; 2017 Oct; 56(5):585-592. PubMed ID: 29037541
[TBL] [Abstract][Full Text] [Related]
38. A cathelicidin antimicrobial peptide from Hydrophis cyanocinctus inhibits Zika virus infection by downregulating expression of a viral entry factor.
Wang J; Jiang B; Wang K; Dai J; Dong C; Wang Y; Zhang P; Li M; Xu W; Wei L
J Biol Chem; 2022 Oct; 298(10):102471. PubMed ID: 36089062
[TBL] [Abstract][Full Text] [Related]
39. Zika Virus Infection with Prolonged Maternal Viremia and Fetal Brain Abnormalities.
Driggers RW; Ho CY; Korhonen EM; Kuivanen S; Jääskeläinen AJ; Smura T; Rosenberg A; Hill DA; DeBiasi RL; Vezina G; Timofeev J; Rodriguez FJ; Levanov L; Razak J; Iyengar P; Hennenfent A; Kennedy R; Lanciotti R; du Plessis A; Vapalahti O
N Engl J Med; 2016 Jun; 374(22):2142-51. PubMed ID: 27028667
[TBL] [Abstract][Full Text] [Related]
40. Zika Virus: Recent Advances towards the Development of Vaccines and Therapeutics.
McArthur MA
Viruses; 2017 Jun; 9(6):. PubMed ID: 28608813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
